The Comparison of the Efficacy and Safety of Arzoxifene versus Raloxifene in Postmenopausal Women with Osteoporosis

Update Il y a 5 ans
Reference: EUCTR2006-001987-22

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to compare the effect of orally administered 20 mg arzoxifene daily versus orally administered 60 mg raloxifene daily on 12-month percent change from baseline in lumbar spine BMD in postmenopausal women with osteoporosis, as assessed by dual energy x-ray absorptiometry DXA .


Inclusion criteria

  • Prevention and treatment of osteoporosis